Analyst Ratings for Nurix Therapeutics
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Nurix Therapeutics (NASDAQ:NRIX) stock. The analysts have an average price target of $30.75 versus the current price of Nurix Therapeutics at $9.5, implying upside. This current average has decreased by 3.91% from the previous average price target of $32.00.
July 24, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts predict an upside for Nurix Therapeutics with an average price target of $30.75, a decrease of 3.91% from the previous target.
The analysts' average price target for Nurix Therapeutics is significantly higher than its current price, indicating a potential upside. However, the decrease in the average price target could suggest a slightly less optimistic outlook compared to previous predictions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100